CPIHF yields 12500.00% · JNJ yields 2.13%● Live data
📍 CPIHF pulled ahead of the other in Year 1
Combined, CPIHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CPIHF + JNJ for your $10,000?
Champion Technology Holdings Limited, an investment holding company, primarily engages in the trading of gasoil and cultural products, sales of renewable energy systems and related engineering work, software development, and licensing and customization of system products in the People's Republic of China, the United Kingdom, and Germany. The company operates through five segments: Sales of Cultural Products, Sales of Surveillance Equipment, Renewable Energy, Trading for Gasoil and Related Business, and Strategic Investments. It is involved in the sales of cultural products, gasoil, and surveillance equipment; design and sale of renewable energy products and solutions; charters vessels; general system products; and provision of systems and related software licensing services, as well as installation and maintenance services; and payment gateways and Internet of Things services. The company also offers e-shopping, Internet-based, e-commerce, and m-commerce services; invests in and leases properties; advertising and recruitment agency services; and trades in pagers and provides messaging services, as well as telecommunication system and products. In addition, it provides management, documentation, and arrangement and business consultant services; messaging services; and consulting, research and development, and telecommunication services. Further, the company engages in the money lending activities; and investing in listed securities. Champion Technology Holdings Limited is based in Shek Tong Tsui, Hong Kong.
Full CPIHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.